A public–private partnership model for COVID-19 diagnostics
Krijger, Peter H.L.; Hoek, Tim A.; Boersma, Sanne; Donders, Lieke I.P.M.; Broeders, Maaike M.C.; Pieterse, Mark; Toonen, Pim W.; Logister, Ive; Verhagen, Bram M.P.; Verstegen, Marjon J.A.M.; van Ravesteyn, Thomas W.; Roymans, Rene J.T.M.; Mattiroli, Francesca; Vandesompele, Jo; Nijhuis, Monique; Meijer, Stefan; van Weert, Anton; Dekker, Edwin; Dom, Fred J.; Ruijtenbeek, Rob; van der Velden, Lieven B.J.; van de Bovenkamp, Jeroen H.B.; Bosch, Martijn; de Laat, Wouter; Tanenbaum, Marvin E.
(2021) Nature Biotechnology, volume 39, issue 10, pp. 1182 - 1184
(Letter)
Download/Full Text
The full text of this publication is not available.
Keywords: Biotechnology, Bioengineering, Applied Microbiology and Biotechnology, Molecular Medicine, Biomedical Engineering
ISSN: 1087-0156
Publisher: Nature Publishing Group
Note: Funding Information: We thank the Foundation Friends of the Hubrecht Institute, the Royal Dutch Academy of Sciences (KNAW), Health~Holland Top Sector Life Sciences & Health, and the Oncode Institute for financial support. We thank Erik van de Linde, members of the VWS Taskforce STRIP-1 and Niek Dubelaar for support. We thank all the members of the Hubrecht Institute who were involved in the early stages of the project, Peter Bredenbeek for SARS-CoV-2 control plasmids and Sietske Bakker for facilitating contact between the Hubrecht Institute and Genmab. We thank G.G.D. Brabant-Zuidoost for help with the collection of clinical specimens for COVID-19 testing. M.N. acknowledges support from Health Holland Clear Covid-19 (LSHM20058) and ZonMw project 114025009. We also thank members of the UMC Utrecht, especially Aniek Janssen, Maria Rodriguez-Colman, Jurian Schuijers, Andreas Sonnen and Rob Schuurman, for discussions. Finally, we thank the Dutch public test service (dienst testen) for support.
(Peer reviewed)